THE ONLY NONINVASIVE SOLUTION THAT OPENS A WINDOW INTO PATIENTS’ HEMODYNAMIC AND FLUID STATUS
YOUR WINDOW TO THE HEART
NICaS is an easy to use, non-invasive, actionable, robust & cost- effective system for the challenging task of treating and monitoring hemodynamic and fluid management problems.
OUR VISION
Our goal is to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, Chronic heart failure, Haemodialysis, ICU/CCU, Neonatal, and treatment of infectious diseases.
The NIMEDICAL- NICAS provides a much needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings.
OUR SOLUTIONS
Stroke Volume, heart failure and Cardiac Output are vital signs that, when monitored, enable the treating physicians to better care for and supervise their patients in a wide variety of clinical applications.
As most traditional methods that measure these parameters, require invasive procedure such as the insertion of a catheter, the use of these parameters in diagnosing heart patients is limited.
Our non-invasive technology enables physicians to measure cardiac parameters in a variety of settings, such as hospitals, clinics or the patient’s home.
Our NICaS technology helps improve medical outcomes, both chronic and acute, in a wide variety of clinical applications including: heart failure management, hypertension control, hemodialysis, preeclampsia, CRT optimization, hemodynamic management during anesthesia and more.
CLINICAL APPLICATION
THE CHALLENGE
OUR SOLUTION
HEART FAILURE
Using NICaS for management of HF patients reduces Hospital
Readmission Rate by over 90%
HYPERTENSION
Only 50% of Hypertensive patients in the US are
under control
Customers who are using NICaS for management of hypertension have reported control rate of over 90%
Preeclampsia
Preeclampsia and eclampsia can lead to increased risks of significant maternal and perinatal adverse outcomes, including death.
NICaS is designed to assist physicians in finding the exact cause of hypertension, thus significantly reducing these risks.
DIALYSIS
NICaS can provide each
patient hemodynamic
profile allowing to set
more accurate dry weight
and treatment strategy
and thus reduce the
amount of unnecessary
hospitalizations
ICU/ICCU
COVID 19
Due to the pandemic, many healthcare systems are overwhelmed and unable to provide optimal respiratory treatment to their patients. In addition, over 20% of COVID 19 patients develop cardiac injury, on top of patients with preexisting cardiac conditions
NICaS can provide accurate and continuous cardiorespiratory
information to optimize the treatment
for patients with ARDS. While limiting
the exposure of medical teams,
it also helps reduce risk of infection.
Pharma Clinical trials
NICaS provides a cost-effective and easy
to use system. With its highly accurate,
sensitive and reproducible information,
NiCaS helps speed up the drug development process.
NICaS MODULAR AND COMPACT DESIGN MAKES IT ACCESSIBLE AND EASY TO USE IN VARIOUS MEDICAL SETTINGS:
CARDIAC ICUs, GENERAL ICUs, INTERNAL WARDS, ERs, ORs, CHF AND HYPERTENSION CLINICS, DIALYSIS, NURSING HOMES, PRIVATE CLINICS, PATIENTS’ HOME
EASY SETUP
SIMPLE OPERATION
REPORT
Flexible and easy to read.
Helps treating physicians prioritize
hemodynamic and fluid parameters
SOME OF OUR REGULATORY
APPROVALS / CLEARANCES
LOCATIONS & DISTRIBUTORS
NI Medical is represented in many countries in North America, South America, Europe and Asia Pacific. In case we do not have a distributor or partner in the country you are looking for, please contact us directly at our headquarter.
THE ONLY NON-INVASIVE SOLUTION THAT OPENS A CLEAR WINDOW INTO PATIENTS’ HEMODYNAMIC AND FLUID STATUS
YOUR WINDOW TO THE HEART
Watch NICaS Intro:
OUR VISION
Our goal is to provide non-invasive solutions to the various challenges in the cardiovascular field. These range from Hypertension, Chronic heart failure, Haemodialysis, ICU/CCU, Neonatal, and treatment of infectious diseases.
The NIMEDICAL- NICAS provides a much needed solution for non-invasive hemodynamic and fluid management in both inpatient and outpatient settings.
OUR SOLUTIONS
Stroke Volume, heart failure and Cardiac Output are vital signs that enable the treating physicians to better treat and monitor their patients – in a wide array of clinical applications.
As Most traditional methods that measure these parameters, require invasive procedure such as the insertion of a catheter – the use of these parameters in diagnosing heart patients is limited.
Our Non Invasive technology enable physicians to measure cardiac parameters in a variety of settings such as hospitals, clinics or the patient’s home.
Our Nicas technology helps improve medical outcomes, both chronically and acutely, in a wide clinical applications including: Heart Failure management, Hypertension control, Hemodialysis, Preeclampsia, CRT optimization, Hemodynamic management during anesthesia and more.
HEART FAILURE
THE CHALLENGE:
Average readmission rate for
Patient with HF is 30%
OUR SOLUTION:
Using NICaS for management of HF patients reduces Hospital
Readmission rate by over 90%
HYPERTENSION
THE CHALLENGE:
Only 50% of Hypertensive patients
in the US are under control
OUR SOLUTION:
Preeclampsia
THE CHALLENGE:
OUR SOLUTION:
NICaS is designed to assist physicians in finding the exact cause of hypertension, thus significantly reducing these risks.
DIALYSIS
THE CHALLENGE:
OUR SOLUTION:
ICU/ICCU
THE CHALLENGE:
While Hemodynamic Information is crucial for Patient management in the ICU only this data is only available for 20-30%
OUR SOLUTION:
COVID 19
THE CHALLENGE:
Due to the pandemic many healthcare systems are being overwhelmed and are unable to provide optimal respiratory treatment to their patients, in addition over 20% of COVID 19 patients develop cardiac injury (this is in addition to the patient with pre-existing cardiac conditions)
OUR SOLUTION:
NICaS can provide an accurate continuous cardiorespiratory information to optimise the treatment for patient with ARDS, while limiting the exposure of medical team and thus risk of infection
Pharma Clinical trials
THE CHALLENGE:
Many drug developers are struggling to evaluate the compounds for cardiac efficacy and safety, due to the high cost and reproducibility limitation of the current methods such as Echocardiography and Thermodilution
OUR SOLUTION:
NICaS provides cost effective easy to use highly accurate, sensitive and reproducible hemodynamic information allowing to speed up the drug development process
NICaS MODULAR AND COMPACT DESIGN MAKES IT ACCESSIBLE AND EASY TO USE IN VARIOUS MEDICAL SETTINGS:
CARDIAC ICUs, GENERAL ICUs, INTERNAL WARDS, ERs, ORs, CHF AND HUYPERTENSION CLINICS, DIALYSIS, NURSING HOMES, PRIVATE CLINICS, PATIENTS’ HOME PATIENTS’ HOME
EASY SETUP
Connect to any device (tablets, laptops, desktops) Easy and quick installation process.
SIMPLE OPERATION
REPORT
SOME OF OUR Regulatory Approvals / Clearances:
LOCATIONS & DISTRIBUTORS
NI Medical is represented in many countries in North America, South America, Europe and Asia Pacific. In case we do not have a distributor or partner in the country you are looking for, please contact us directly at our headquarter.